Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Characterization of a novel human BFL-1-specific monoclonal antibody.

ABSTRACT:

SUBMITTER: Gangoda L

PROVIDER: S-EPMC7206078 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Characterization of a novel human BFL-1-specific monoclonal antibody.

Gangoda Lahiru L Teh Charis E CE Dengler Michael A MA Best Sarah A SA Weeden Clare E CE Tai Lin L Lee Erinna F EF Fairlie Walter D WD Sutherland Kate D KD Harrison Leonard C LC Gray Daniel H DH Strasser Andreas A Herold Marco J MJ

Cell death and differentiation 20191112 2

PMID: 31719651

Similar Datasets

Preparation and characterization of a fully human monoclonal antibody specific for human tumor necrosis factor alpha.

Project description: Not available

| S-EPMC8809985 | biostudies-literature

Human RP105 monoclonal antibody enables the production of antigen-specific antibody

Project description:Antibody detection is a critical approach in clinical contexts. Detecting antibodies, particularly those directed against donor HLA in organ transplantation and self-antigens in autoimmune diseases, is crucial in diagnosis and therapy. Radioprotective 105 (RP105, CD180 ), a type I transmembrane protein with structural similarities to Toll-like receptor 4, is expressed in immune-competent cells, such as B cells. Studies involving mice have reported that the antimouse RP105 antibody strongly activates B cells and triggers an adjuvant effect against viral infections. However, the antihuman RP105 antibody (ɑhRP105) weakly activates human B cells. In this study, we established new culture conditions under which human B cells are strongly activated by ɑhRP105. When combined with CpGDNA, this activation induced a heightened production of interleukin 6. Under these culture conditions, specific antibody production against blood group carbohydrates, ɑGal, and SARS-CoV-2 within supernatants from human B-cell cultures was successfully detected. Furthermore, comprehensive analysis employing LC/MS/MS analysis and single-cell RNA sequencing revealed that ɑhRP105 triggered a different activation stimulus from CpGDNA. These findings could be applied to developing a straightforward approach for identifying antibody-producing B cells in cases involving transplant rejection and autoimmune diseases.

2024-09-13 | GSE241135 | GEO

Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas.

Project description: Not available

| S-EPMC5758533 | biostudies-literature

A novel human monoclonal antibody specific to the A33 glycoprotein recognizes colorectal cancer and inhibits metastasis.

Project description: Not available

| S-EPMC6999842 | biostudies-literature

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.

Project description: Not available

| S-EPMC7048180 | biostudies-literature

Characterization of a novel inhibitory human monoclonal antibody directed against Plasmodium falciparum Apical Membrane Antigen 1.

Project description: Not available